These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 7490884)

  • 21. Urinary levels of tumor-associated trypsin inhibitor (TATI) in the detection of transitional cell carcinoma of the urinary bladder.
    Shariat SF; Herman MP; Casella R; Lotan Y; Karam JA; Stenman UH
    Eur Urol; 2005 Sep; 48(3):424-31. PubMed ID: 15963628
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of cytokeratin 20 in urinary cytology of patients with bladder carcinoma.
    Klein A; Zemer R; Buchumensky V; Klaper R; Nissenkorn I
    Cancer; 1998 Jan; 82(2):349-54. PubMed ID: 9445193
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cellular fibronectin in patients with transitional cell carcinoma of the bladder.
    Hegele A; Heidenreich A; Varga Z; von Knobloch R; Olbert P; Kropf J; Hofmann R
    Urol Res; 2003 Feb; 30(6):363-6. PubMed ID: 12599015
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased immunodetection of acidic fibroblast growth factor in bladder cancer, detectable in urine.
    Chopin DK; Caruelle JP; Colombel M; Palcy S; Ravery V; Caruelle D; Abbou CC; Barritault D
    J Urol; 1993 Oct; 150(4):1126-30. PubMed ID: 7690426
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recovery of epidermal growth factor in voided urine of patients with bladder cancer.
    Messing EM; Murphy-Brooks N
    Urology; 1994 Oct; 44(4):502-6. PubMed ID: 7941190
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inverse relation of E-cadherin and autocrine motility factor receptor expression as a prognostic factor in patients with bladder carcinomas.
    Otto T; Birchmeier W; Schmidt U; Hinke A; Schipper J; Rübben H; Raz A
    Cancer Res; 1994 Jun; 54(12):3120-3. PubMed ID: 8205527
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Autocrine motility factor receptor: a clinical review.
    Chiu CG; St-Pierre P; Nabi IR; Wiseman SM
    Expert Rev Anticancer Ther; 2008 Feb; 8(2):207-17. PubMed ID: 18279062
    [TBL] [Abstract][Full Text] [Related]  

  • 28. BTA TRAK urine test increases the efficacy of cytology in the diagnosis of low-grade transitional cell carcinoma of the bladder.
    Gibanel R; Ribal MJ; Filella X; Ballesta AM; Molina R; Alcaraz A; Alcover JB
    Anticancer Res; 2002; 22(2B):1157-60. PubMed ID: 12168917
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sensitivity and specificity of urinary hyaluronic acid and hyaluronidase in detection of bladder transitional cell carcinoma.
    Jamshidian H; Hashemi M; Nowroozi MR; Ayati M; Bonyadi M; Najjaran Tousi V
    Urol J; 2014 Mar; 11(1):1232-7. PubMed ID: 24595930
    [TBL] [Abstract][Full Text] [Related]  

  • 30. THE SIGNIFICANCE OF EPIDERMAL GROWTH FACTOR RECEPTOR AND SURVIVIN EXPRESSION IN BLADDER CANCER TISSUE AND URINE CYTOLOGY OF PATIENTS WITH TRANSITIONAL CELL CARCINOMA OF THE URINARY BLADDER.
    Kehinde EO; Al-Maghrebi M; Anim JT; Kapila K; George SS; Al-Juwaiser A; Memon A
    East Afr Med J; 2013 Jan; 90(1):19-27. PubMed ID: 26862626
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Non-invasive molecular detection of bladder cancer recurrence.
    Amira N; Mourah S; Rozet F; Teillac P; Fiet J; Aubin P; Cortesse A; Desgrandchamps F; Le Duc A; Cussenot O; Soliman H
    Int J Cancer; 2002 Sep; 101(3):293-7. PubMed ID: 12209982
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Urinary levels of urokinase-type plasminogen activator and its receptor in the detection of bladder carcinoma.
    Casella R; Shariat SF; Monoski MA; Lerner SP
    Cancer; 2002 Dec; 95(12):2494-9. PubMed ID: 12467062
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative evaluation of the nuclear matrix protein, fibronectin, urinary bladder cancer antigen and voided urine cytology in the detection of bladder tumors.
    Eissa S; Swellam M; Sadek M; Mourad MS; El Ahmady O; Khalifa A
    J Urol; 2002 Aug; 168(2):465-9. PubMed ID: 12131289
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rapid detection of urinary long non-coding RNA urothelial carcinoma associated one using a PCR-free nanoparticle-based assay.
    Eissa S; Matboli M; Essawy NO; Shehta M; Kotb YM
    Biomarkers; 2015; 20(3):212-7. PubMed ID: 26161701
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Highly sensitive and specific novel biomarkers for the diagnosis of transitional bladder carcinoma.
    Kumar P; Nandi S; Tan TZ; Ler SG; Chia KS; Lim WY; Bütow Z; Vordos D; De la Taille A; Al-Haddawi M; Raida M; Beyer B; Ricci E; Colombel M; Chong TW; Chiong E; Soo R; Park MK; Ha HK; Gunaratne J; Thiery JP
    Oncotarget; 2015 May; 6(15):13539-49. PubMed ID: 25915536
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of the NMP22 test and comparison with voided urine cytology in the detection of bladder cancer.
    Lee KH
    Yonsei Med J; 2001 Feb; 42(1):14-8. PubMed ID: 11293494
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of urinary bladder cancer antigen as a marker for diagnosis of transitional cell carcinoma of the urinary bladder.
    Heicappell R; Schostak M; Müller M; Miller K
    Scand J Clin Lab Invest; 2000 Jul; 60(4):275-82. PubMed ID: 10943597
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection of mucin 7 gene expression in exfoliated cells in urine from patients with bladder tumor.
    Okegawa T; Kinjo M; Horie S; Nutahara K; Higashihara E
    Urology; 2003 Jul; 62(1):182-6. PubMed ID: 12837463
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Telomerase activity in patients with transitional cell carcinoma: a preliminary study.
    Rahat MA; Lahat N; Gazawi H; Resnick MB; Sova Y; Ben-Ari G; Cohen M; Stein A
    Cancer; 1999 Feb; 85(4):919-24. PubMed ID: 10091771
    [TBL] [Abstract][Full Text] [Related]  

  • 40. E-cadherin tissue expression and urinary soluble forms of E-cadherin in patients with bladder transitional cell carcinoma.
    Shi B; Laudon V; Yu S; Dong D; Zhu Y; Xu Z
    Urol Int; 2008; 81(3):320-4. PubMed ID: 18931551
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.